[EN] PYRROLOPYRIMIDINE ITK INHIBITORS<br/>[FR] INHIBITEURS DE PYRROLOPYRIMIDINE ITK
申请人:ACLARIS THERAPEUTICS INC
公开号:WO2020033955A1
公开(公告)日:2020-02-13
Disclosed herein are arylpyridinone compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structures of Formulas (I) -(IV): wherein the R groups, m, n, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.